Stock Market News
Stress tests to unleash shareholder returns at RBS, Morgan Stanley says
Upcoming stress test results should trigger the release of a large amount of pent-up regulatory capital at RBS, analysts at Morgan Stanley said as they bumped-up their target price for the shares.
Also, continued growth in its Retail arm and in mortgages was seen delivering compound annual growth of 3% over the next three years, alleviating margin pressures, facilitating a strong margin build and therefore capital returns.
Together with the lender's existing room to manoeuvre when it comes to improving the efficiency of its capital structure, that should allow for a normal dividend payout of 40%, special dividends, and a £2.0bn share buyback programme.
Combined, their expectation was that those factors would drive total shareholder returns of 23% between 2018 and 2020.
Hence their decision on Tuesday to boost their target price for the shares from 315p each to 335p, while reiterating their 'overweight' stance on the same.
"RBS remains our preferred UK domestic name. The stock is trading on 9x adjusted earnings vs. the sector on 11.7x while offering one of the highest shareholder return profiles in Europe together with Lloyds and Nordic banks. We would regard an interim dividend as a show of confidence from the regulator and a catalyst for the stock," they said.
Critical to their investment thesis, on Morgan Stanley's estimates RBS was sporting a 2018 common equty Tier 1 capital ratio of 16.4%, versus their estimate of a steady-state requirement for 13.5%.
Hence, once it passed those stress tests, RBS should be able to pay-out "at least" 100% of its projected earnings for 2019/2020 in the form of dividends.
On top of that, the broker believed there was room to call, tender or redeem £6.0bn-worth of the legacy £18.0bn of subordinated debt instruments sitting on its balance sheet.
That might save it about £200m over the next three years, Morgan Stanley said, which its analysts had previously not factored-in.
"Beyond that we see further room to go as AT1s and more Tier 2 instruments get refinanced," they added.
RBS was unlikely to act imminently, the analysts explained, given current cash prices.
But the $6.425%, $7.648% Tier 1s and the $7.125% and $7.75% Tier 2s issued by RBS NV were all deemed "attractive tender opportunities".
Also, continued growth in its Retail arm and in mortgages was seen delivering compound annual growth of 3% over the next three years, alleviating margin pressures, facilitating a strong margin build and therefore capital returns.
Together with the lender's existing room to manoeuvre when it comes to improving the efficiency of its capital structure, that should allow for a normal dividend payout of 40%, special dividends, and a £2.0bn share buyback programme.
Combined, their expectation was that those factors would drive total shareholder returns of 23% between 2018 and 2020.
Hence their decision on Tuesday to boost their target price for the shares from 315p each to 335p, while reiterating their 'overweight' stance on the same.
"RBS remains our preferred UK domestic name. The stock is trading on 9x adjusted earnings vs. the sector on 11.7x while offering one of the highest shareholder return profiles in Europe together with Lloyds and Nordic banks. We would regard an interim dividend as a show of confidence from the regulator and a catalyst for the stock," they said.
Critical to their investment thesis, on Morgan Stanley's estimates RBS was sporting a 2018 common equty Tier 1 capital ratio of 16.4%, versus their estimate of a steady-state requirement for 13.5%.
Hence, once it passed those stress tests, RBS should be able to pay-out "at least" 100% of its projected earnings for 2019/2020 in the form of dividends.
On top of that, the broker believed there was room to call, tender or redeem £6.0bn-worth of the legacy £18.0bn of subordinated debt instruments sitting on its balance sheet.
That might save it about £200m over the next three years, Morgan Stanley said, which its analysts had previously not factored-in.
"Beyond that we see further room to go as AT1s and more Tier 2 instruments get refinanced," they added.
RBS was unlikely to act imminently, the analysts explained, given current cash prices.
But the $6.425%, $7.648% Tier 1s and the $7.125% and $7.75% Tier 2s issued by RBS NV were all deemed "attractive tender opportunities".
Related share prices |
---|
Lloyds Banking Group (LLOY) share price |
Royal Bank of Scotland Group (RBS) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price